The UC San Diego Medical Entrepreneurship Education and Training (MEET) program, organized by the Rady School of Management and Health Sciences and facilitated by the Altman Clinical and Translational Research Institute (ACTRI), provides funding to advance health and healthcare-oriented UC San Diego technologies to commercial impact. Funding of $5,000-$50,000 is available for milestone-based projects to advance the commercial potential of projects that have completed proof-of-concept phases of development. The aim of this funding is to accelerate the transition from completed proof-of-concept innovations to commercial viability, such as the development of a start-up entity or viable licensing arrangement. Teams seeking matching funding commitment for de-risking their projects and advancing them to commercialization are particularly welcome. The program is supported by state funds through the bill AB2664.
Twelve-24 months of funding support are available for faculty. Projects may include software-based technologies, devices, diagnostics, therapeutics or materials but must be pertinent to some aspect of healthcare or health sciences. Initial funds will be disbursed in July 2017 and subsequent installmentsmade available based on progress. Because this program offers a rapid turnaround for funding decisions and award initiation, this call for proposals is intended for teams that have preliminary data on their innovation and are ready to move into the commercialization phase.
Applications are completed through an online form and are due by 5 p.m. on June 26, 2017. Late applications will not be considered.
Apply online: MEET Application Packet Upload
Applications due: June 26, 2017 by 5 p.m.
Notice of awards: July 15, 2017
The program is open to UC San Diego faculty
Proposals should be designed for completion within 12 to 24 months and reflect a milestone-based structure.
Projects involving university intellectual property (IP) require a disclosure on file with the Office of Innovation & Commercialization, and any IP must be available for licensing. IP generated in the course of the project must be assignable to UC San Diego. If your technology originates from UC San Diego and you have not filed disclosure with OIC, or if you have questions regarding intellectual property status, please contact OIC for discussion. OIC encourages the use of the eDisclosure system in filing invention-related disclosures. More information can be found on Blink.
USE OF FUNDS
Funding of $5,000 to $50,000 is available for each award.
Funds are flexible and may be used to support additional research activities that generate additional validation data, reduce the risks to the commercialization path of novel approaches, refine prototypes, or otherwise advance research toward commercial impact.
Eligible costs include materials and supplies, prototyping costs, use of facilities, and other essential expenses. Faculty may request support for student and postdoc salaries, stipends, or partial fellowships. Supported students must be enrolled full-time at UC San Diego and in good academic standing.
Funds may not support faculty salaries (including summer), basic research, clinical trials, legal expenses, general-use capital purchases, or publication. No indirect costs apply.
The funding period will begin in July 2017. Funding will be disbursed in a minimum of two tranches based on individual milestones. Funds must be spent in accordance with submitted budget. Eligible costs must be incurred after notice of the award and all funds must be spent within the time period specified by the award.
The application process is designed to assess the originality and viability of proposed projects. Proposals should not include confidential/proprietary information.
Proposals will be reviewed on the following criteria:
- Innovation and technical excellence. What preliminary data is available to evidence proof-of-concept? Is the project achievable within a 12-month timeframe? What is the significance of the proposed approach, and how does it differ from existing solutions?
- Commercial potential. Has the technology been disclosed to OIC (if applicable)? Can a market opportunity be identified? What is the role for industry engagement?
- Availability of Matching Funds. Are other sources of funds available with which these funds can be leveraged against?
- Team. Is there evidence that team can deliver the project?
- Project and Commercialization Plan. Does the proposal address a perceived obstacle to commercial application? Does the project plan lend itself to well-defined milestones leading toward a commercial endpoint?
- Financial justification. Are costs well justified? Will support enable the team to achieve significant milestones that would not otherwise be possible?
Successful applicants will work with OIC and the MEET Advisory Board to report ongoing project milestones. Final reports are due at the conclusion of the project period. Recipients will be invited to participate in roundtable and/or showcase opportunities.
Activities funded through this program are subject to university IP policies and guidelines.
Industry engagement is a cornerstone of the program, with experts participating in a voluntary, advisory capacity, and so an open flow of information is encouraged to the extent it does not increase the risk of the path to commercialization.
Awards will be announced publicly in July, 2017. The full proposal includes a section requesting a synopsis appropriate for public use.
For projects involving UC San Diego intellectual property, OIC officers are available to discuss disclosure requirements.
For specific questions or concerns, please contact Karen Jensen at email@example.com.